Picture of Abionyx Pharma SA logo

ABNX — Abionyx Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: ABIONYX Pharma FY Net Income Turns To Loss Of 1.9 Million Euros

Feb 25 (Reuters) - ABIONYX PHARMA SA  ABNX.PA :
    * ANNUAL RESULTS 2020
    * NET RESULT WAS A LOSS OF EUR 1,886 K AT 31 DECEMBER 2020
COMPARED WITH A PROFIT OF EUR 1,849 K AT 31 DECEMBER 2019
    * CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 9,154 K AT 31
DECEMBER
2020, COMPARED WITH EUR 8,331 K AT 31 DECEMBER 2019
    * FY: NO REVENUE
    * OPERATING PROFIT FELL FROM A LOSS OF EUR 2,525 K AT 31
DECEMBER
2019 TO A LOSS OF EUR 2,968 K AT 31 DECEMBER 2020
    * FY NET LOSS EUR 1.9 MILLION VERSUS PROFIT OF EUR 1.8
MILLION
YEAR AGO

Source text for Eikon:  ID:nBw5pHvY2a 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Abionyx Pharma SA

See all news